Increased costs of diabetes therapy not related to glycemic control at three veterans affairs medical outpatient clinics

P and T

Volumn 29, Issue 8, 2004, Pages 500-506

  Fultz, Shawn L ^a,b,c   Good, C Bernie ^d,e   Kelley, Mary E ^e   Fine, Michael J ^d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d Vet Aff Pittsburgh Hlth Care S   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Economics; Outcome and process assessment (health care); Pharmaceutical; Physicians' practice patterns; Veterans

Indexed keywords

ACARBOSE; CORTICOSTEROID; DIURETIC AGENT; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

ADULT; AGED; ARTICLE; DEVICE; DIABETES MELLITUS; DRUG COST; FEMALE; GLUCOSE BLOOD LEVEL; GOVERNMENT; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL PRACTICE; OUTPATIENT DEPARTMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; SOLDIER; TREATMENT INTENSITY; TREATMENT OUTCOME; VETERANS AFFAIRS HEALTHCARE SYSTEM;

EID: 4143072380     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Diabetes Association. Diabetes 1996, Vital Statistics. Alexandria, VA: 1996.
2. Pogach LM, Hawley G, Weinstock R, et al. Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994): Use of an ambulatory care pharmacy-derived database. Diabetes Care 1998;21(3):368-373.
3. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329(5): 304-309.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986.
5. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Practice Suppl 1995;28(2):103-117.
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131):837-853.
7. Genuth S. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 1996;124(1 Pt 2):104-109.
8. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association. Diabetes Care 1998;21(2): 296-309.
9. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997;20(9):1396-1402.
10. Krop JS, Powe NR, Weller WE, et al. Patterns of expenditures and use of services among older adults with diabetes: Implications for the transition to capitated managed care. Diabetes Care 1998; 21(5):747-752.
11. Glauber HS, Brown JB. Use of health maintenance organization data bases to study pharmacy resource usage in diabetes mellitus. Diabetes Care 1992;15(7):870-876.
12. Rathmann W, Haastert B, Roseman JM, et al. Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care 1998;21(3):389-397.
13. Department of Veterans Affairs. Pharmacy Database, v 30. Hines, IL: Pharmacy Benefits Strategic Healthcare Group, 2002. Available at: www1.va.gov/health/diabetes/default.htm.
14. Ho M, Marger M, Beart J, et al. Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic? Diabetes Care 1997;20(4):472-475.
15. Krein SL, Hofer TP, Kerr EA, Hayward RA. Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res 2002;37(5):1159-1180.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40(5):373-383.
17. Lazaridis EN, Qiu C, Kraft SK, Marrero DG. Same eyes, different doctors: Differences in primary care physician referrals for diabetic retinopathy screening. Diabetes Care 1997;20(7): 1073-1077.
18. Streja DA, Rabkin SW. Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med 1999;159(3):294-302.
19. Kraft SK, Lazaridis EN, Qiu C, et al. Screening and treatment of diabetic nephropathy by primary care physicians. J Gen Intern Med 1999;14(2):88-97.
20. Glasgow RE, Boles SM, Calder D, et al. Diabetes care practices in primary care: Results from two samples and three measurement sets. Diabetes Educator 1999;25(5):755-763.
21. Chin MH, Zhang JX, Merrell K. Specialty differences in the care of older patients with diabetes. Med Care 2000;38(2):131-140.
22. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects: A criteria-based literature review. Diabetes Care 1997;20(9):1482-1486.
23. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111(1):1-9.
24. Gallichan M. Self-monitoring of glucose by people with diabetes: Evidence-based practice. BMJ 1997;314 (7085):964-967.
25. Department of Veterans Affairs. Management of patients with diabetes mellitus in the primary care setting. August 24, 2003. Available at: www.oqp.med.va.gov/cpg/DM/DM_base.htm.
26. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352(9131):854-865.